クレマスチン
1%/タベジール散1% 添付文書”. www.info.pmda.go.jp. PMDA. 2021年6月12日閲覧。
↑ “タベジールシロップ0.01% 添付文書”. www.info.pmda.go.jp. PMDA. 2021年6月12日閲覧。
↑ Tevell, Annica, et al. (2004). “Identification of some new clemastine metabolites in dog, horse, and human urine with liquid chromatography/tandem mass spectrometry”. Rapid communications in mass spectrometry 18 (19): 2267-2272. doi:10.1002/rcm.1622.
↑ Hamelin, Bettina A., et al. (1998). “In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists”.
Drug metabolism and disposition 26 (6): 536-539. https://dmd.aspetjournals.org/content/26/6/536.short 2022年3月1日閲覧。.
↑ 『新しい疾患薬理学』Katsunori Iwasaki, Shōgo Tokuyama, 岩崎克典., 徳山尚吾.、南江堂、Tōkyō、2018年、223頁。ISBN 978-4-524-40335-6。OCLC 1030482447。https://www.worldcat.org/oclc/1030482447。
↑ “Identification of novel functional inhibitors of acid sphingomyelinase”. PLOS ONE 6 (8): e23852. (2011). doi:10.1371/journal.pone.0023852. PMC 3166082. PMID 21909365. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166082/.